Indonesia orders to stop the sale of syrups after the death of almost 100 children

The health authorities of Indonesia They urged this Wednesday to stop the sale of all types of syrups after the death of 99 children from kidney failure since January, while dozens of deaths of minors in Gambia from the same cause are potentially associated with medicines manufactured in India.

The spokesman for the Ministry of Health IndonesiaMohammad Syahril, said today at a press conference that “Since the end of August there has been an increase in cases of kidney failure among minors that has drawn our attention.”

LOOK: The version of the Indonesian police on the death of the Peruvian trans activist from Harvard who was on his honeymoon in Bali

So far this year, the ministry has recorded 206 cases of kidney failure in children, of which 99 have died, while “previously the usual was one or two cases of childhood kidney injury per month,” he said, although they did not reveal the total number of conditions and deaths for this reason last year.

Syahril stressed that the causes of acute kidney failure are still under investigation and there will be more results next week, while the Indonesian director general of health services urged today to temporarily suspend the sale of all types of syrups in the archipelago until there are more inquiries.

The emergency arises after last October 6 the World Health Organization (WHO) issued a warns about four cough and cold syrups produced by the Indian laboratory Maiden Pharmaeuticals, that could have caused the death by kidney failure of more than 60 children in The Gambia.

Until now, the Indonesian authorities have claimed that these products were not available in the Southeast Asian nation.

In his alert, the WHO indicated that the four products are promethazine oral solution, “Kofexmalin” and “Makoff” cough syrups for babies, and “Magrip N” cold syrup from the manufacturer Maiden Pharmaceuticals Limited (Haryana, India).

“Laboratory analysis of samples of each of the four products confirms that they contain unacceptable amounts of diethylene glycol and ethylene glycol as contaminants.”indicated the WHO.

According to the UN agency, “diethylene glycol and ethylene glycol are toxic to humans when consumed and can be fatal,” and their effects include “abdominal pain, vomiting, diarrhea, inability to urinate, headache, altered state mental illness and acute kidney injury that can cause death.

The WHO also indicated that, to date, the four products had been identified only in The Gambia, for which they were initially manufactured exclusively, but that they may have been distributed through informal markets to other countries.

Maiden Pharmaceuticals has been in business for more than 30 years and operates two plants in India, both in the northern state of Haryana, for the production of capsules, injectables, liquid syrup, ointments and tablets that are sold in countries in Asia, Africa and the Americas. America, according to the company itself.

Source: Elcomercio

Ronald Payne

I, Ronald Payne, am a journalist and author who dedicated his life to telling the stories that need to be said. I have over 7 years of experience as a reporter and editor, covering everything from politics to business to crime.